These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 15448217

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Combination of rituximab with combined pulse-therapy with high doses of methylprednisolone and cyclophosphamide: effects on immunomorphological and functional disturbances of the salivary glands in a patient with Sjogren's disease and MALT-lymphoma].
    Vasil'ev VI, Kokosadze NV, Logvinenko OA, Nikitin EA, Mitrikov BV, Rodionova EB, Varlamova EIu.
    Ter Arkh; 2008; 80(5):76-9. PubMed ID: 18590121
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Successful treatment with rituximab in a patient with primary thymic MALT lymphoma complicated with acquired von Willebrand syndrome and Sjögren syndrome].
    Iwabuchi T, Kimura Y, Suzuki T, Hayashi H, Fujimoto H, Hashimoto Y, Ogawa T, Kusama H, Fukutake K, Ohyashiki K.
    Rinsho Ketsueki; 2011 Apr; 52(4):210-5. PubMed ID: 21566407
    [Abstract] [Full Text] [Related]

  • 8. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis.
    Niscola P, Palumbo R, Scaramucci L, Tendas A, Cupelli L, Giovannini M, Piccioni D, Dentamaro T, Perrotti AP, de Fabritiis P.
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):759-60. PubMed ID: 18500519
    [No Abstract] [Full Text] [Related]

  • 9. Multiple nodular lesions of the chin and oral mucosa in a patient with Sjögren's syndrome.
    Stinchi C, Piraccini BM, Pileri S, Lorenzi S, Casavecchia P, Fanti PA, Tosti A.
    Eur J Dermatol; 1998 Mar; 8(5):350-2. PubMed ID: 9683860
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prolonged remission of a demyelinating neuropathy in a patient with lymphoma and Sjögren's syndrome after Rituximab therapy.
    Botez SA, Herrmann DN.
    J Clin Neuromuscul Dis; 2010 Mar; 11(3):127-31. PubMed ID: 20215986
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.
    De Vita S, Quartuccio L, Salvin S, Picco L, Scott CA, Rupolo M, Fabris M.
    Clin Exp Rheumatol; 2014 Mar; 32(4):490-4. PubMed ID: 24802131
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.